Pay in 4 interest-free payments of $5.12 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Monney M, Mavromati M, Leboulleux S, Gariani K
The tennis super star is one of a growing list of celebrities turning to GLP-1s, drugs originally developed to treat patients with Type II diabetes and obesity, to help with weight loss
We would recommend choosing this option over the others if you are already using Hims for other products, as it can make ordering more convenient by keeping everything in one place and avoiding the need to manage multiple accounts
To be eligible for the BELIEVE study, participants must have a body mass index (BMI) greater than or equal to 30, or greater than or equal to 27 with one or more obesity-related comorbidities
&srotate=0)
Retatrutide (LY3437943) is an investigational triple-agonist (GLP-1, GIP, glucagon) and is not an approved therapy
US$ 23.08
US$ 25.25
US$ 24.45
US$ 27.80
